FDA and industry reach agreement in principle on medical device user fees
The FDA and representatives from the medical device industry have reached an agreement in principle on proposed recommendations for the third reauthorization of a medical device user fee program. The recommendations would authorize the FDA to collect $595M in user fees over five years, plus adjustments for inflation. Details of the agreement, such as the fee structure, are expected to be finalized soon. :theflyonthewall.com
Thermo Fisher target raised to $62 from $57 at Cantor
Cantor increased its target on Thermo Fisher after the company reported stronger than expects Q4 results. The firm thinks that the company is continuing to execute well, and maintains a Buy rating. :theflyonthewall.com
Subscribe for More Information
